NL-OMON55091
Recruiting
Not Applicable
Vaccination response to pneumococcal antigen as novel predictor for successful tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia. - The VaccinSTOP study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Albert Schweitzer Ziekenhuis
- Enrollment
- 57
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Aged 18 years or older
- •\- Written informed consent
- •\- Known baseline data on diagnosis and treatment prior to study entry
- •\- Eligible for TKI discontinuation according to current HOVON guidelines (anno
- •2018\) on the treatment of CML
Exclusion Criteria
- •\- Previously vaccinated against S. pneumoniae
- •\- Known allergy to any constituent of the pneumococcal vaccine
- •\- Patients using any immunosuppressive medication, excluding inhalation
- •corticosteroids and ointments containing corticosteroids
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Immune response test as new predictor for successful TKI stop in patients with chronic myeloid leukemiaChronic myeloid leukemiaMedDRA version: 21.0Level: LLTClassification code 10009016Term: Chronic myeloid leukemia in remissionSystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10009015Term: Chronic myeloid leukemiaSystem Organ Class: 100000004864MedDRA version: 21.0Level: LLTClassification code 10054352Term: Chronic phase chronic myeloid leukemiaSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2020-002850-26-NLAlbert Schweitzer Hospital57
Completed
Phase 4
The antibody response to pneumococcal vaccination in patients with inflammatory bowel disease patients treated with immunosuppressive agentsantibody responseprotection after vaccination1001796910027665NL-OMON45696Academisch Medisch Centrum178
Recruiting
Not Applicable
De antistof respons na pneumokokkenvaccinatie bij IBD-patiënten die behandeld worden met immunosuppressiva – de PNEUMOREACT studieinflammatory bowel disease (inflammatoire darmziekte)immunosuppressive agents (immunosuppressiva)pneumococcal vaccination (pneumokokkenvaccinatie)vaccine immunogenicity (vaccin immunogeniciteit)NL-OMON29135Academic Medical Center188
Active, not recruiting
Not Applicable
Immune response to pneumococcal conjugate vaccine in adults receiving hepatitis A vaccine concomitantly18 years old or older volunteers with general good healthEUCTR2012-003484-22-FIHelsinki University Central Hospital600
Active, not recruiting
Not Applicable
Immune response to pneumococcal conjugate vaccine in adults receiving hepatitis A vaccine concomitantlyEUCTR2012-003484-22-SEHelsinki University Central Hospital300